An Mll-dependent Hox program drives hematopoietic progenitor expansion.

Area of Science:

• Hematopoiesis research
• Molecular biology
• Cancer genetics

Background:

• Mixed lineage leukemia (Mll) gene is crucial for hematopoietic stem cell (HSC) development.
• Chromatin regulators like MLL and Trithorax influence gene expression, including Hox genes.
• The collective role of Hox genes in mammalian hematopoiesis is complex due to paralog redundancy.

Purpose of the Study:

• To investigate the role of MLL and its target Hox genes in hematopoietic progenitor development.
• To determine if Hox gene reexpression can rescue hematopoietic defects in Mll-deficient cells.

Main Methods:

• Analysis of hematopoietic progenitors in Mll-deficient mice.
• Assessment of Hox gene expression levels.
• Functional assays measuring hematopoietic colony formation and growth.
• Rescue experiments involving reexpression of MLL target genes.

Main Results:

• Mll deficiency leads to reduced expression of HoxA, HoxB, and HoxC genes in early hematopoietic progenitors.
• These progenitors show significantly impaired ability to form hematopoietic colonies.
• Reactivating a subset or even a single Hox gene restored colony frequency and growth.
• Other MLL targets like Pitx2 or BCL-2 failed to rescue the hematopoietic defect.

Conclusions:

• Hox genes play a critical, shared role in the later stages of hematopoietic development, specifically in cell division and differentiation.
• MLL's regulation of Hox genes is essential for maintaining hematopoietic progenitor function.
• Targeted Hox gene reexpression may offer therapeutic potential for MLL-related leukemias.